𝔖 Bobbio Scriptorium
✦   LIBER   ✦

DUSP4 deficiency enhances CD25 expression and CD4+ T-cell proliferation without impeding T-cell development

✍ Scribed by Ching-Yu Huang; Yu-Chun Lin; Wan-Yi Hsiao; Fang-Hsuean Liao; Pau-Yi Huang; Tse-Hua Tan


Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
987 KB
Volume
42
Category
Article
ISSN
0014-2980

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

The differentiation and activation of T cells are critically modulated by MAP kinases, which are in turn feed‐back regulated by dual‐specificity phosphatases (DUSPs) to determine the duration and magnitude of MAP kinase activation. DUSP4 (also known as MKP2) is a MAP kinase‐induced DUSP member that is dynamically expressed during thymocyte differentiation. We generated DUSP4‐deficient mice to study the function of DUSP4 in T‐cell development and activation. Our results show that thymocyte differentiation and activation‐induced MAP kinase phosphorylation were comparable between DUSP4‐deficient and WT mice. Interestingly, activated DUSP4^−/−^ CD4^+^ T cells were hyperproliferative while DUSP4^−/−^ CD8^+^ T cells proliferated normally. Further mechanistic studies suggested that the hyperproliferation of DUSP4^−/−^ CD4^+^ T cells resulted from enhanced CD25 expression and IL‐2 signaling through increased STAT5 phosphorylation. Immunization of DUSP4^−/−^ mice recapitulated the T‐cell hyperproliferation phenotype in antigen recall responses, while the profile of Th1/Th2‐polarized antibody production was not altered. Overall, these results suggest that other DUSPs may compensate for DUSP4 deficiency in T‐cell development, MAP kinase regulation, and Th1/Th2‐mediated antibody responses. More importantly, our data indicate that DUSP4 suppresses CD4^+^ T‐cell proliferation through novel regulations in STAT5 phosphorylation and IL‐2 signaling.


📜 SIMILAR VOLUMES


Inhibition of human T cell proliferation
✍ Claire N. Manzotti; Helen Tipping; Laura C. A. Perry; Karen I. Mead; Patrick J. 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 263 KB 👁 2 views

CD28 and CTLA-4 are opposing regulators of T cell activation, triggered by the two ligands CD80 and CD86. How these ligands promote either T cell activation via CD28 or inhibition via CTLA-4 is not understood. Using CD80 and CD86 molecules expressed on transfected cells, we have identified a major d

Differential response of murine CD4+CD25
✍ Xin Chen; Takaya Murakami; Joost J. Oppenheim; O. M. Zack Howard 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 381 KB

## Abstract To evaluate the __in vivo__ effect of immunosuppressive glucocorticoids on CD4^+^CD25^+^ T regulatory cells, we injected dexamethasone (Dex) into BALB/c mice. Administrationof Dex enhanced the proportion of CD4^+^CD25^+^ cells and the ratio of CD4^+^CD25^+^ cells to CD4^+^CD25^–^ cells